Mao Ding
Impact in
- Geriatrics and Gerontology top 10%
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Alzheimer's disease research and treatments 5
-
- Extracellular vesicles in disease 2
- Co-authors
- Shujie Xia (3 shared papers)Bangmin Han (4 shared papers)Chenyi Jiang (3 shared papers)Xian-Jin Xie (1 shared paper)Xun Wang (1 shared paper)Yaqin Zhang (1 shared paper)Shanchen Pang (1 shared paper)Jing Zhao (1 shared paper)
- Journals
- Journal of Experimental & Clinical Cancer Research (3 papers)BMC Nephrology (2 papers)Neuroreport (2 papers)Journal of Alzheimer s Disease (2 papers)Structural and Multidisciplinary Optimization (1 paper)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Mao Ding
24 papers receiving 465 citations
Peers
Comparison fields: 5 of 84
- Geriatrics and Gerontology 31
- Cancer Research 105
- Neurology 28
- Pulmonary and Respiratory Medicine 79
- Molecular Biology 176
Countries citing papers authored by Mao Ding
This map shows the geographic impact of Mao Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mao Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mao Ding more than expected).
Fields of papers citing papers by Mao Ding
This network shows the impact of papers produced by Mao Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mao Ding. The network helps show where Mao Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Mao Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 72 | |
| 2 | 2020 | 65 | |
| 3 | 2020 | 63 | |
| 4 | 2019 | 60 | |
| 5 | 2021 | 33 | |
| 6 | 2018 | 28 | |
| 7 | 2018 | 28 | |
| 8 | 2023 | 18 | |
| 9 | 2019 | 18 | |
| 10 | 2022 | 15 | |
| 11 | 2021 | 10 | |
| 12 | 2018 | 10 | |
| 13 | 2022 | 10 | |
| 14 | 2024 | 9 | |
| 15 | 2025 | 8 | |
| 16 | 2021 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2021 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 2 |
About Mao Ding
Mao Ding is a scholar working on Physiology, Molecular Biology, Pulmonary and Respiratory Medicine, Nutrition and Dietetics and Cancer Research, having authored 25 papers that have together received 470 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (5 papers), Trace Elements in Health (3 papers), Urologic and reproductive health conditions (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Extracellular vesicles in disease (2 papers), Prostate Cancer Treatment and Research (2 papers) and Tryptophan and brain disorders (2 papers). The work is most often cited by research in Geriatrics and Gerontology (31 citations), Cancer Research (105 citations), Neurology (28 citations), Pulmonary and Respiratory Medicine (79 citations) and Molecular Biology (176 citations). Mao Ding has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Shujie Xia, Bangmin Han, Chenyi Jiang, Xian-Jin Xie, Xun Wang, Yaqin Zhang, Shanchen Pang, Jing Zhao, Yu Zhang and Zhaohong Xie. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, BMC Nephrology, Neuroreport, Journal of Alzheimer s Disease and Structural and Multidisciplinary Optimization.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.